沉默HOXA13基因对肝癌HepG2和QGY-7703细胞恶性表型的影响

doi:10.13481/j.1671-587x.20180220

吉林大学学报(医学版) ›› 2018, Vol. 44 ›› Issue (02): 315-320.doi: 10.13481/j.1671-587x.20180220

沉默HOXA13基因对肝癌HepG₂和QGY-7703细胞恶性表型的影响

张艳霞¹, 李跃辉², 张丽红¹, 张年萍¹, 闫燕艳¹, 杨小会³, 冯湘玲³

1. 山西大同大学医学院, 山西大同 037009;
2. 中南大学基础医学院肿瘤研究所, 湖南长沙 410078;
3. 中南大学湘雅公共卫生学院, 湖南长沙 410078

收稿日期:2017-05-02 出版日期:2018-03-28 发布日期:2018-03-30
通讯作者: 杨小会,讲师(Tel:0731-84805311,E-mail:yangxiaohui0924@163.com);冯湘玲,副教授,硕士研究生导师(Tel:0731-84805311,E-mail:Fengxl@csu.edu.cn) E-mail:yangxiaohui0924@163.com;Fengxl@csu.edu.cn
作者简介:张艳霞(1978-),女,山西省大同市人,医学硕士,主要从事消化道肿瘤方面的研究。
基金资助:
山西省科技厅基础研究计划项目资助课题（20140210376）；山西大同大学校级科研项目资助课题（2017K9）

Effects of silencing HOXA13 gene on malignant phenotypes of hepatocellular carcinoma HepG₂ and QGY-7703 cells

ZHANG Yanxia¹, LI Yuehui², ZHANG Lihong¹, ZHANG Nianping¹, YAN Yanyan¹, YANG Xiaohui³, FENG Xiangling³

1. School of Medical Sciences, Shanxi Datong University, Datong 037009, China;
2. Cancer Research Institute, School of Basic Medical Sciences, Central South University, Changsha 410078, China;
3. School of Xiangya Public Health, Central South University, Changsha 410078, China

Received:2017-05-02 Online:2018-03-28 Published:2018-03-30

摘要/Abstract

摘要： 目的：探讨沉默HOXA13基因对肝癌细胞株HepG₂与QGY-7703恶性表型的影响，为肝癌的诊断及治疗提供新的分子靶点。方法：构建HOXA13基因的干扰重组质粒plent-U6-GFP/si-HOXA13，将其稳定转染至HepG₂与QGY-7703细胞；采用RT-PCR和Western blotting法鉴定干扰效果；以HOXA13基因沉默细胞为实验组，以转染空质粒的细胞为对照组，采用四甲基偶氮唑蓝（MTT）法、细胞倍增时间测定、平板克隆形成实验和流式细胞术等分析HOXA13基因沉默后HepG₂与QGY-7703细胞生长速度、细胞倍增时间、克隆形成能力和细胞周期等的改变。结果：MTT实验，与对照组比较，实验组细胞的生长速度明显下降；其细胞周期也发生改变，G₁期细胞增多、S期细胞减少。对照组HepG₂和QGY-7703细胞平均倍增时间分别为（4.59±0.27）和（4.93±0.17） h，实验组HepG₂和QGY-7703细胞平均倍增时间分别为（6.02±0.86）和（6.43±0.66） h，2组间比较差异有统计学意义（P<0.05）。对照组HepG₂和QGY-7703细胞平均细胞克隆形成数分别为（264.00±12.62）和（269.00±4.55）个，实验组HepG₂和QGY-7703细胞平均细胞克隆形成数目分别为（165.00±10.61）和（215.00±4.43）个，2组比较差异有统计学意义（P<0.01）。结论：HOXA13基因可以使肝癌细胞HepG₂与QGY-7703的增殖加快、克隆形成能力增强、G₁期细胞减少、S期细胞增多，可以成为肝癌诊断和治疗新的分子靶点。

关键词: HOXA13, 克隆形成, 肝肿瘤, 细胞周期, 细胞增殖

Abstract: Objective:To investigate the effects of silencing HOXA13 gene on the malignant phenotypes of hepatocellular carcinoma cell lines HepG₂ and QGY-7703,and to provide a new molecular target for the diagnosis and treatment of hepatocellular carcinoma. Methods: The interference recombinant plasmid of plent-U6-GFP/si-HOXA13 was constructed,then it was stably transfected into the HepG₂ and QGY-7703 cells.The interfering effects of HOXA13 gene were determined by RT-PCR and Western blotting methods.The HepG₂ and QGY-7703 cells transfected with HOXA13 knockdown were used as experimental group,and the HepG₂ and QGY-7703 cells transfected with empty plasmid were used as control group.Then the growth speed was examined by MTT assay,the cell doubling time was examined by double time assay,the colony formation ability was examined by colony formation assay,and the cell cycle was examined by flow cytometry. Results: The MTT assay results showed that compared with control group,the growth speeds of HepG₂ and GY-7703 cells in experimental group were significantly decreased and the cell cycles were changed; the number of HepG₂ and QGY-7703 cells in G₁ phase was increased and the number of cells in S phase was decreased.The doubling time of HepG₂ and QGY-7703 cells in control group and experimental group were (4.59±0.27),(4.93±0.17),(6.02±0.86), and (6.43±0.66)h,and the differences between control group and experimental group were significant(P<0.05).The colony number of HepG₂ and QGY-7703 cells in control group and experimental group were 264.00±12.62,269.00±4.55,165.00±10.61, and 215.00±4.43,and the differences between control group and experimental group were significant(P<0.01). Conclusion: HOXA13 can increase the proliferation,enhance the clone formation,decrease the number of cells at G₁ phase and increase the number of cells at S phase in the hepatocellular carcinoma HepG₂ and QGY-7703 cells; and it may used as a new molecular target for diagnosis and treatment of hepatocellular carcinoma.

Key words: cell proliferation, colony formation, HOXA13, liver neoplasms, cell cycle, malignant phenotype

中图分类号:

R730.2

张艳霞, 李跃辉, 张丽红, 张年萍, 闫燕艳, 杨小会, 冯湘玲. 沉默HOXA13基因对肝癌HepG₂和QGY-7703细胞恶性表型的影响[J]. 吉林大学学报(医学版), 2018, 44(02): 315-320.

ZHANG Yanxia, LI Yuehui, ZHANG Lihong, ZHANG Nianping, YAN Yanyan, YANG Xiaohui, FENG Xiangling. Effects of silencing HOXA13 gene on malignant phenotypes of hepatocellular carcinoma HepG₂ and QGY-7703 cells[J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 315-320.

参考文献

[1] 杨小会,李跃辉,冯湘玲.同源异型盒基因甲基化与实体肿瘤的研究进展[J].医学临床研究,2017,34(9):1739-1742.
[2] Chang CJ,Chen YL,Hsieh CH,et al.HOXA5 and p53 cooperate to suppress lung cancer cell invasion and serve as good prognostic factors in non-small cell lung cancer[J].Cancer,2017,8(6):1071-1081.
[3] Xia B,Shan M,Wang J,et al.Homeobox A11 hypermethylation indicates unfavorable prognosis in breast cancer[J].Oncotarget,2017,8(6):9794-9805.
[4] Xue M,Zhu FY,Chen L,et al.HoxB9 promotes the migration and invasion via TGF-β1/Smad2/Slug signaling pathway in oral squamous cell carcinoma[J].Am J Transl Res,2017,9(3):1151-1161.
[5] Cillo C,Schiavo G,Cantile M,et al.The HOX gene network in hepatocellular carcinoma[J].Int J Cancer,2011,129(11):2577-2587.
[6] Sauvegarde C,Paul D,Bridoux L,et al.Dynamic pattern of HOXB9 protein localization during oocyte maturation and early embryonic development in mammals[J].PLoS ONE,2016,11(10):e0165898.
[7] Li YH,Yang XH,Fang SJ,et al.HOXA7 stimulates human hepatocellular carcinoma proliferation through cyclin E1/CDK2[J].Oncol Rep,2015,33(2):990-996.
[8] Armas-López L,Piña-Sánchez P,Arrieta O,et al.Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance,overall survival and therapy prognosis in lung cancer patients[J].Oncotarget,2017,8(40):67056-67081.
[9] Brechka H,Bhanvadia RR,VanOpstall C,et al.HOXB13 mutations and binding partners in prostate development and cancer:Function,clinical significance,and future directions[J].Genes Dis,2017,4(2):75-87.
[10] Li M,Li X,Zhuang Y,et al.Induction of HOXA9 expression in three-dimensional organotypic culture of the Claudin-low breast cancer cells[J].Oncotarget,2016,7(32):51503-51514.
[11] Vider BZ,Zimber A,Chastre E, et al.Deregulated expression of homeobox-containing genes,HOXB6,B8,C8,C9,and Cdx-1,in human colon cancer cell lines[J].Biochem Biophys Res Commun,2000,272(2):513-518.
[12] Abe M,Hamada J,Takahashi O,et al.Disordered expression of HOX genes in human non-small cell lung cancer[J].Oncol Rep,2006,15(4):797-802.
[13] Kanai M,Hamada J,Takada M,et al.Aberrant expressions of HOX genes in colorectal and hepatocellular carcinomas[J].Oncol Rep,2010,23(3):843-851.
[14] Quagliata L,Quintavalle C,Lanzafame M,et al.High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models[J].Lab Invest,2018,98(1):95-105.
[15] 沙亮,何剑波,李科志,等.特异性下调LKB1的表达对肝癌细胞侵袭迁移能力的影响[J].临床肝胆病杂志,2016,33(5):875-879.
[16] Gu ZD,Shen LY,Wang H,et al.HOXA13 promotes cancer cell growth and predicts poor survival of patients with esophageal squamous cellcarcinoma[J].Cancer Res,2009,69(12):4969-4973.

沉默HOXA13基因对肝癌HepG₂和QGY-7703细胞恶性表型的影响

Effects of silencing HOXA13 gene on malignant phenotypes of hepatocellular carcinoma HepG₂ and QGY-7703 cells

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	朱德强, 陈学军. 白花丹素对肝癌索拉菲尼耐药细胞HepG2R增殖和凋亡的影响及其机制[J]. 吉林大学学报(医学版), 2018, 44(06): 1223-1229.
[2]	阎慧, 马淑飞, 段明华, 闫玉礼, 潘新, 李海清, 周长龙, 赵天倚. 京尼平对胃癌SGC 7901细胞体外增殖、侵袭能力和凋亡的影响及其机制[J]. 吉林大学学报(医学版), 2018, 44(05): 924-928.
[3]	邢树刚, 张丽红, 金明华, 李百慧, 武则馨, 房波, 李伟. 杨梅黄酮对小鼠脑胶质瘤GL261细胞增殖和凋亡的影响[J]. 吉林大学学报(医学版), 2018, 44(05): 955-961.
[4]	薛亚娟, 符兆英. 人乳头瘤病毒致癌特性及其E6和E7蛋白致癌机制的研究进展[J]. 吉林大学学报(医学版), 2018, 44(05): 1096-1099.
[5]	袁虎勤, 李强. 水飞蓟素对人胃癌SGC 7901细胞增殖、迁移和侵袭的抑制作用及其机制[J]. 吉林大学学报(医学版), 2018, 44(05): 988-993.
[6]	刘定坤, 杨楠, 金巨楼, 孙梦洁, 王倩, 吴佳, 刘志辉. 牙髓干细胞增殖、分化和迁移的研究进展[J]. 吉林大学学报(医学版), 2018, 44(05): 1100-1104.
[7]	王淼, 母润红, 李明成, 李洪杰. RNAi沉默survivin和HIF-1α基因对胃癌BGC-823细胞体外增殖和凋亡的影响[J]. 吉林大学学报(医学版), 2018, 44(04): 753-758.
[8]	李鑫, 马云飞, 唐庚, 韦麒, 纪红池, 田嘉安, 申延男, 王志成. 线粒体靶向KillerRed诱导的ROS增强辐射对HeLa细胞的增殖抑制作用[J]. 吉林大学学报(医学版), 2018, 44(04): 718-723.
[9]	朱效慧, 孟琴, 冯世燕. TP53在不明原因复发性流产患者绒毛组织中的表达及其对人滋养层细胞生长的影响[J]. 吉林大学学报(医学版), 2018, 44(04): 796-800.
[10]	李天柱, 王加茹, 张俊毅, 王洪权, 史铁伟, 周静, 白春英, 金成浩. ELK-3蛋白在肝癌组织中的表达及其对肝癌HepG2细胞迁移和侵袭能力的影响[J]. 吉林大学学报(医学版), 2018, 44(04): 736-740.
[11]	吕鹏, 宁明杰, 邵玉, 张璐妮, 唐英, 王南博, 陈飞儿, 齐玲. 野黄芩苷对人脑胶质瘤U87细胞的增殖抑制作用及其机制[J]. 吉林大学学报(医学版), 2018, 44(03): 466-470.
[12]	杨文延, 刘强, 孙志娟, 杜利清, 徐畅, 王彦, 柳杨, 王芹. 褪黑素对人非小细胞肺癌H1299细胞辐射敏感性的影响[J]. 吉林大学学报(医学版), 2018, 44(03): 532-536.
[13]	邢少姬, 郑连生, 王殿栋, 张萱, 池敏. 硒蛋白S基因单核苷酸多态性与肝癌发病风险的关联性分析[J]. 吉林大学学报(医学版), 2018, 44(03): 558-562.
[14]	周刘祥, 林琳, 胡鑫敏, 王晓春. 内分泌腺性血管内皮生长因子对结肠癌LoVo细胞增殖和迁移的促进作用[J]. 吉林大学学报(医学版), 2018, 44(03): 516-520.
[15]	刘霞, 齐凤杰, 杜晓媛. 沉默CRAF基因表达对肝癌细胞侵袭和迁移的影响[J]. 吉林大学学报(医学版), 2018, 44(03): 521-525.